telmisartan has been researched along with Recrudescence in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, TH; Li, YR; Lin, YS; Liu, CH; Sung, PS; Wei, YC | 1 |
| Feng, J; Gan, Y; Jiang, H; Ma, H | 1 |
| Chen, H; Du, R; Han, H; Hu, L; Li, J; Li, W; Ma, L; Tian, L; Zhou, Q | 1 |
| Bath, PM; Cotton, D; Diener, HC; Ovbiagele, B; Sha, N | 1 |
| Bath, PM; Cotton, D; Estol, CJ; Gorelick, PB; Martin, RH | 1 |
| Pan, G; Zhao, J; Zhou, X | 1 |
| Biasucci, LM; Capogrossi, MC; Crea, F; Dato, I; De Maria, GL; Di Vito, L; Leone, AM; Paglia, A; Porto, I; Tritarelli, A | 1 |
| Bath, PM; Cotton, D; Diener, HC; Donnan, GA; Martin, RH; Ovbiagele, B; Vinisko, R; Yusuf, S | 1 |
| Derosa, G; Fogari, R; Maffioli, P; Mugellini, A; Perrone, T; Preti, P; Zoppi, A | 1 |
| Carbotta, S; Cittadini, A; Di Michele, S; Galzerano, D; Gaudio, C; Lama, D; Paolisso, G; Tedesco, MA; Tuccillo, B | 1 |
2 review(s) available for telmisartan and Recrudescence
| Article | Year |
|---|---|
Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Calcium Channel Blockers; Humans; Hypertension; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Telmisartan | 2021 |
Effect of telmisartan on atrial fibrillation recurrences in patients with hypertension: a systematic review and meta-analysis.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Chi-Square Distribution; Humans; Hypertension; Kaplan-Meier Estimate; Odds Ratio; Recurrence; Risk Assessment; Risk Factors; Telmisartan; Treatment Outcome | 2014 |
6 trial(s) available for telmisartan and Recrudescence
| Article | Year |
|---|---|
Effects of telmisartan on paroxysmal atrial fibrillation in hypertensive patients.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fibrillation; Biomarkers; Blood Pressure; C-Reactive Protein; China; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Recurrence; Telmisartan; Time Factors; Treatment Outcome | 2017 |
Low glomerular filtration rate, recurrent stroke risk, and effect of renin-angiotensin system modulation.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cohort Studies; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Male; Middle Aged; Proportional Hazards Models; Recurrence; Renin-Angiotensin System; Risk Factors; Stroke; Telmisartan; Time Factors | 2013 |
Differences in ischemic and hemorrhagic recurrence rates among race-ethnic groups in the PRoFESS secondary stroke prevention trial.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Therapy, Combination; Ethnicity; Female; Humans; Intracranial Hemorrhages; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Secondary Prevention; Stroke; Telmisartan | 2014 |
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events.
Topics: AC133 Antigen; Acute Coronary Syndrome; Aged; Angiotensin-Converting Enzyme Inhibitors; Antigens, CD; Antigens, CD34; Benzimidazoles; Benzoates; C-Reactive Protein; Female; Flow Cytometry; Glycoproteins; Hematopoietic Stem Cells; Humans; Linear Models; Male; Middle Aged; Peptides; Prospective Studies; Ramipril; Recurrence; Telmisartan | 2011 |
Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Calcium Channel Blockers; Double-Blind Method; Female; Heart Atria; Humans; Hypertension; Male; Recurrence; Risk Factors; Telmisartan | 2012 |
A multicentre, randomized study of telmisartan versus carvedilol for prevention of atrial fibrillation recurrence in hypertensive patients.
Topics: Adult; Aged; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Female; Heart Ventricles; Humans; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Organ Size; Propanolamines; Recurrence; Telmisartan | 2012 |
3 other study(ies) available for telmisartan and Recrudescence
| Article | Year |
|---|---|
Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study.
Topics: Aged; Antihypertensive Agents; Brain Ischemia; Databases, Factual; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Taiwan; Telmisartan; Time Factors; Treatment Outcome | 2020 |
Level of systolic blood pressure within the normal range and risk of recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Blood Pressure; Brain Ischemia; Clopidogrel; Diastole; Dipyridamole; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Reference Values; Risk; Stroke; Systole; Telmisartan; Ticlopidine; Vascular Diseases | 2011 |
[PRoFESS study presented. Change in secondary prevention].
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Controlled Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Placebos; Platelet Aggregation Inhibitors; Recurrence; Risk; Stroke; Telmisartan; Ticlopidine; Time Factors | 2003 |